RxDoctor Payments Data

Nilofar Sarvaiya, MD

Psychiatry · Buffalo, NYNPI 1134548910

Payments from drug & device makers

$1,450in general payments, 2019–2025

Across 52 payments — averaging $27.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$544
  • Alkermes, Inc.$399
  • Teva Pharmaceuticals USA, Inc.$154
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$143
  • Vanda Pharmaceuticals Inc.$46
  • Axsome Therapeutics, Inc.$42
  • plus $122 from 4 others

What the payments were for

  • Food & beverage$1,450100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,450 in reported general payments places this provider in the 80th percentile of 3,713 psychiatry providers in New York.

See all psychiatry providers in New York

Medicare billing

Part B allowed, 2024
$7,407
Medicare patients
27
Services billed
114

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate12$90,978
Risperdal ConstaRisperidone Microspheres13$16,522
RexultiBrexpiprazole11$16,223
Clozapine112$11,538
NuedextaDextromethorphan Hbr/Quinidine11$8,931
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl18$6,033
Desvenlafaxine Succinate ErDesvenlafaxine Succinate36$4,959
Vilazodone Hcl21$2,876
Aripiprazole43$2,033
Quetiapine Fumarate ErQuetiapine Fumarate18$1,721
Buspirone Hcl62$1,702
Divalproex Sodium ErDivalproex Sodium15$1,690
Haloperidol Decanoate34$1,657
Olanzapine53$1,406
Risperidone48$1,297

Paid to pharmacies, not to this prescriber.

Other psychiatry in Buffalo

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →